Addendum: Newly Diagnosed Papillary Craniopharyngioma With Braf V600E Mutation Treated With Single-Agent Selective Braf Inhibitor Dabrafenib: A Case Report

Authors

• Mayank Rao
• Meenakshi Bhattacharjee
• Scott Shepard
• Sigmund Hsu

Language

English

Publication Date

5-10-2023

Journal

Oncotarget

DOI

10.18632/oncotarget.28428

PMID

37163235

PMCID

PMC10171364

PubMedCentral® Posted Date

5-10-2023

PubMedCentral® Full Text Version

Post-print

Comments

Original article: Oncotarget. 2019; 10:6038–6042. 6038-6042. https://doi.org/10.18632/oncotarget.27203

Published Open-Access

yes

Recommended Citation

Rao, Mayank; Bhattacharjee, Meenakshi; Shepard, Scott; et al., "Addendum: Newly Diagnosed Papillary Craniopharyngioma With Braf V600E Mutation Treated With Single-Agent Selective Braf Inhibitor Dabrafenib: A Case Report" (2023). Faculty, Staff and Student Publications. 3854.
https://digitalcommons.library.tmc.edu/uthmed_docs/3854